3 Year results of a prospective case control study using reduced dose calcineurin inhibitor (CNI) with sirolimus (SRL) compared to full dose CNI with mycophenylate mofetil (MMF) for immunosuppression in kidney transplantation.

被引：0
|
作者：
Formica, RN [1 ]
Kulkarni, SL [1 ]
Friedman, AL [1 ]
Bia, MJ [1 ]
Lorber, MI [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
336
引用
收藏
页码：241 / 241
页数：1
相关论文
共 6 条
  • [1] Comparison of efficacy and safety of sirolimus(SLR) and mycophenolate mofetil(MMF) as adjunct to calcineurin inhibitor(CNI) based steroid free immunosuppression in kidney transplantation.
    Kumar, MSA
    Fyfe, B
    Sierka, D
    Heifets, M
    Saeed, MI
    Parikh, MH
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 578 - 578
  • [2] Kidney transplantation with sirolimus and mycophenolate mofetil based immunosuppression preserves renal structure and function compared to calcineurin inhibitor (CNI) drugs.
    Flechner, SM
    Solez, K
    Cook, DJ
    Burke, JT
    Rollin, H
    Mastoianni, B
    Savas, K
    Kurian, S
    Head, S
    Salomon, DR
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 296 - 296
  • [3] Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs
    Flechner, Stuart M.
    Goldfarb, David
    Solez, Kim
    Modlin, Charles S.
    Mastroianni, Barbara
    Savas, Kathy
    Babineau, Denise
    Kurian, Sunil
    Salomon, Daniel
    Novick, Andrew C.
    Cook, Daniel J.
    [J]. TRANSPLANTATION, 2007, 83 (07) : 883 - 892
  • [4] Pilot study of thymoglobulin (THY) followed by sirolimus (SRL) as maintenance monotherapy. a calcineurin inhibitor (CNI) free, steroid sparing and likely tolerogenic protocol for kidney transplantation (ktx): 5 year follow up.
    Donati, Donato
    Ambrosini, Andrea
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 160 - 161
  • [5] Conversion to low-dose tacrolimus/sirolimus or sirolimus monotherapy after liver transplantation and calcineurin inhibitor induced nephroxicity results in stabilization or improvement of kidney function - A prospective study.
    Uhlmann, D
    Pridoehl, O
    Rhein, T
    Bartels, M
    Max, D
    Tannapfel, A
    Hauss, J
    Witzigmann, H
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 472 - 472
  • [6] LIVING-RELATED VERSUS LIVING-UNRELATED KIDNEY TRANSPLANTATION USING EVEROLIMUS PLUS REDUCED CALCINEURIN INHIBITOR IMMUNOSUPPRESSION: 2-YEAR RESULTS FROM THE A1202 STUDY
    Nakagawa, Ken
    Kenmochi, Takashi
    Kamisawa, Osamu
    Watarai, Yoshihiko
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 399 - 399
1